B2V017 AF NFT

Uracil-DNA glycosylase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicnccypqbgz7wuqakg334rpz5niw543yxxcgsqwshvaekrys4fa24/metadata.json
IPFS of structure file: 
bafybeigtgqzwuznvd6r4apphudqc4ajjboigc23rqjbiowmch73u55fo7q/AF-B2V017-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xdaa356CE75bf1C8E9543ad52A89B7C7C41D2bcDB
First NFT owner address (bech32): 
genesis1m234dnn4huwga92r44f23xmu03qa90xmzz3dkm
Current NFT ID #488758 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
488758
Accession (UniProt):
B2V017
Name::
Uracil-DNA glycosylase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V017 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V017|UNG_CLOBA Uracil-DNA glycosylase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=ung PE=3 SV=1 MNNILKNDWNNYIGNEFEKDYYLKLRKNLAQEYKTKTIYPDMYNIFNALHYTAFDDVKVVILGQDPYHGPNQAHGLSFSVNPGVRTPPSLLNIYKELKDDIGCYIPNNGYLKKWADQGVLLLNTVLTVRAGEANSHKNIGWQIFTDNIIKVLNTREKPIVFILWGNNAIRKEELITNPKHHIIKSVHPSPLSASRGFFGSKPFSKTNEFLKNDNEIPIDWQIENL